Ignite Creation Date:
2025-12-25 @ 4:12 AM
Ignite Modification Date:
2026-05-18 @ 10:41 AM
Study NCT ID:
NCT02718820
Status:
COMPLETED
Last Update Posted:
2024-01-09
First Post:
2016-03-15
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Pembrolizumab Plus Docetaxel for the Treatment of Recurrent or Metastatic Head and Neck Cancer
Sponsor:
Organization: